WallStSmart
NERV

Minerva Neurosciences Inc

NASDAQ: NERV · HEALTHCARE · BIOTECHNOLOGY

$6.47
+1.25% today

Updated 2026-04-30

Market cap
$281.90M
P/E ratio
P/S ratio
1.87x
EPS (TTM)
$-34.67
Dividend yield
52W range
$1 – $9
Volume
0.3M

Minerva Neurosciences Inc (NERV) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+50.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-4.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-8.8%
2026-03-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$0.00+100.0%$8.00$7.30-8.8%
2025-11-05$-0.36-2.9%$3.67$3.64-0.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.11$0.00+100.0%
2025-09-30$-0.35$-0.36-2.9%
2025-06-30$-0.90$-0.43+52.2%
2025-03-31$-1.07$-0.50+53.3%$42218.00
2024-12-31$-1.05$-0.56+46.7%$42218.00
2024-09-30$-1.01$2.97+394.1%
2024-06-30$-0.97$-1.09-12.4%
2024-03-31$-1.20$-1.13+5.8%
2023-12-31$-0.88$-1.39-58.0%
2023-09-30$-0.77$-1.03-33.8%
2023-06-30$-0.44$-1.12-154.5%
2023-03-31$-1.63$-1.31+19.6%
2022-12-31$-0.92$-1.26-37.0%

Frequently asked questions

Has Minerva Neurosciences Inc beaten earnings estimates?
Minerva Neurosciences Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +50.7% over the last 4 quarters.
How does NERV stock react to earnings?
NERV stock has moved an average of -4.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.